Movatterモバイル変換


[0]ホーム

URL:


CN102766701B - The kit of HCV gene typing and method - Google Patents

The kit of HCV gene typing and method
Download PDF

Info

Publication number
CN102766701B
CN102766701BCN201210229235.9ACN201210229235ACN102766701BCN 102766701 BCN102766701 BCN 102766701BCN 201210229235 ACN201210229235 ACN 201210229235ACN 102766701 BCN102766701 BCN 102766701B
Authority
CN
China
Prior art keywords
probe
hcv
type
kit
internal reference
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210229235.9A
Other languages
Chinese (zh)
Other versions
CN102766701A (en
Inventor
彭春梅
胡守旺
谢佐福
周晓强
姚铭锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUZHOU TRIPLEX BIOSCIENCES Co Ltd
Original Assignee
FUZHOU TRIPLEX BIOSCIENCES Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUZHOU TRIPLEX BIOSCIENCES Co LtdfiledCriticalFUZHOU TRIPLEX BIOSCIENCES Co Ltd
Priority to CN201210229235.9ApriorityCriticalpatent/CN102766701B/en
Publication of CN102766701ApublicationCriticalpatent/CN102766701A/en
Application grantedgrantedCritical
Publication of CN102766701BpublicationCriticalpatent/CN102766701B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Landscapes

Abstract

The present invention relates to a kind of disease pathogen technique of gene detection, relate in particular to a kind of kit and method of HCV gene typing, can be used for the type 1a of the HCV that detects domestic generation, 1b, 2a, 2b, 3a, the auxiliary diagnosis that 6a infects. The present invention adopts nylon membrane carrier, for HCV different genotype design oligonucleotides probe, is prepared into genetic chip, then is equipped with PCR primer and other components, can quick and precisely carry out somatotype to HCV in blood sample. The genetic chip of HCV gene typing of the present invention and kit and method have quick, sensitive, accurate, high-throughout feature, one time hybridization reaction can detect multiple target sequence, draw materials conveniently, without special installation, instrument drop into low, have fast and convenient, susceptibility is high and the feature of high specificity.

Description

The kit of HCV gene typing and method
Technical field
The present invention relates to a kind of disease pathogen technique of gene detection, relate in particular to a kind of HCV gene typingKit and method, for detection of the type 1a of the HCV of domestic generation, 1b, 2a, 2b, 3a, it is auxiliary that 6a infectsHelp diagnosis.
Background technology
HCV (hepatitisCvirus, HCV), hepatitis C is worldwide distribution, and crowd is generally easySense is serious harm human health, Epidemic Scope infectious disease widely. Its pathogen is HCV (hepatitisCVirus, HCV). At present, its infection rate is 0.1%-10%, average out to 3%. The whole world has and exceedes 1.7 hundred million people's HCV infection, whereinHave every year to exceed 100,000 routine HCV patients and develop into liver cancer, and then occur hemorrhage of digestive tract and ascites. According to WHO2002Report, in calendar year 2001, chronic liver disease causes that 1,400 ten thousand examples are dead, comprise 79.6 ten thousand examples by cirrhosis cause, 61.6 ten thousand examples are by formerProperty liver cancer causes.
HCV is positivity single stranded RNA flavivirus, comprises a 9400 left and right nucleotides. HCV genome has independent openingPut reading frame, gene structure is made up of 5 '-NCR-C-E1-E2-NS1-NS2-NS3-NS4-NS5-N-CR-3 ', and coding one has3010 amino acid whose polyprotein bodies, are divided into virus replication and virion and form necessary structure and non-structure after translationAlbumen. HCV has variability highly, and (its aberration rate is up to 1.4-1.9 × 10-3/ nucleotides/year) and itself there is negative selectionThe feature of effect, high sudden change is because replicase is without calibration function; Easily mistake property RDRP (error-proneRDRP, EP-RDRP)Existence and the reason such as selection effect just. Show as and itself there is negative selection effect: various bases in viral genomeBecause of structure and function difference, some region height is conservative. The not whole or portion of homophyletic of HCV separating according to different regions, the whole worldDivide genomic phylogenetic analysis, HCV is divided into 6 kinds of main genotype (representing with 1-6), and the various hypotype of dividing is again (with a, b, cDeng expression). HCV hypotype has exceeded 100, and wherein modal is 1a, 1b, and 2a, 2b, 3a, 6a, between various nucleotide sequenceDiffer 31-34%, it is about 30% that amino acid sequence differs, and between hypotype sequence, differ about 20-23%. There are several HCV diseasesStrain is mainly separated from Southeast Asia, is named as HCV7, and 8,9,10,11 types, except HCV10a type (is put at presentHCV3 type), due to the similitude on its phyletic evolution, all the other various HCV6 types that are put into.
Research shows, between the different types of HCV, the susceptibility of interferon therapy is differed, and particularly 1 type is compared with other typeSusceptibility is particularly poor. The infectious hepatitis of different type HCV, the moderate that it is acute, chronic and severe, posthepatitic cirrhosis and formerProperty liver cancer incidence has difference, and the clinical state of an illness of HCV genotype and hepatitis C patients and the order of severity thereof are closely related. In view ofDifferent HCV genotype the infecteds' clinical manifestation, the hepatopathy order of severity and chronicity course advancement are all variant, antiviral therapyEffect also different. Therefore detect complexity, formulation individuation antiviral therapy side that HCV genotype contributes to judgement treatmentCase.
At present HCV methods of genotyping is mainly contained: restricted length polymorphism analysis method (RFLP), Serotype-dependentPrimer PCR method, Serotype-dependent probe nucleic acid hybridization analysis method, the methods such as direct sequencing, but these methods are deposited mostlyThe shortcomings such as at complex operation, high to equipment requirement, detection time is long, and flux is low, also exists sensitivity low, and specificity is not high.
Summary of the invention
The object of the invention is to overcome defect and the deficiency of prior art, manufacture third type with high flux, high accuracyThe genetic chip of virogene of hepatitis somatotype and kit and method, can disposablely accurately divide HCV in multiple samplesType detects, and saves detection time.
Technical solution of the present invention, for a kind of kit of HCV gene typing is provided, mainly comprises PCR reactionLiquid and DNA hybond membrane bar, described DNA hybond membrane bar comprises nylon membrane, on described nylon membrane, is fixed with probe, described probe is canWith the nucleotides of the nucleic acid hybridization of the various subtype virus of HCV, described probe sequence is as follows respectively:
For HCV1a type designing probe Y1:5 '-AATTGCCAGGACGACCGG-3 ';
For HCV1b type designing probe Y2:5 '-AATTGCCAGGATGACCGGG-3 ';
For HCV1b type designing probe Y3:5 '-CCCGGAATTGCCAGGAC-3 ';
For HCV2a type designing probe Y4:5 '-CAATGCCTGGAGATTTGGGCG-3 ';
For HCV2a type designing probe Y5:5 '-CAATGCCTGGAGATTTGGGC-3 ';
For HCV2b type designing probe Y6:5 '-CTCAATGCCTGGAGATTTGG-3 ';
For HCV2b type designing probe Y7:5 '-GCTCAATGCCTGGAGATTTGG-3 ';
For HCV3a type designing probe Y8:5 '-CAATGCCTGGAGATTTGGG-3 ';
For HCV3a type designing probe Y9:5 '-CGAGGTAGACGTCAGCC-3 ';
For HCV3a type designing probe Y10:5 '-ACCTCGAGGTAGACGTCAGCC-3 ';
For HCV6a type designing probe Y11:5 '-AACCTCGAGGTAGACGTCAGCC-3 ';
For HCV6a type designing probe Y12:5 '-GCAACCTCGAGGTAGACGT-3 ';
For HCV6a type designing probe Y13:5 '-TAGACGTCAGCCTATCCCCAA-3 ';
For HCV1-6 type design general probe (being positive probe HP) Y14:5 '-TAGACGCCAGCCTATTCCCA-3 ';
Negative probe HN:5 '-GGTCCTGTTTAACTGGCG-3 ';
Described each probe 5 ' end carry out amino labeled with nylon membrane coupling.
Preferably, in the kit of above-mentioned HCV gene typing, on described nylon membrane, be also provided with colour developing controlManufacturing probe CC, described colour developing control probe CC sequence is as follows: 5 '-GCGCAGGGCCACAATAATGG-3 ', described cc probe5 ' end carries out amino labeled, and 3 ' end carries out biotin labeling.
Preferably, in the kit of above-mentioned HCV gene typing, described PCR reactant liquor comprises amplification the third type liverThe primer of the nucleic acid of scorching viral various subtype virus, described primer sequence is as follows:
Reverse transcriptase primer RT:5 '-CGTCTAGCCATGGCGTTAGT-3 ';
Upstream primer F:5 '-GAAAGCGTCTAGCCATGGCGTTAGT-3 ';
Downstream primer R:5 '-CGCAAGCACCCTATCAGGCAGTA-3 '.
5 ' the end of described upstream primer F carries out biotin labeling.
Preferably, in the kit of above-mentioned HCV gene typing, described PCR reactant liquor also comprises internal reference systemSystem, described internal reference system is arabidopsis internal reference system, comprising:
Internal reference primers F 1:5 '-TCATCGTCGCTGGAGCTGGTT-3 ';
Internal reference primer R1:5 '-CGGCGGTTTGTCAAGCTGAT-3 ';
Internal reference probe PC:5 '-TGCCGATATAGGTCACAGCATGGGC-3 ';
5 ' end of described internal reference primers F 1 carries out biotin labeling.
Preferably, in the kit of above-mentioned HCV gene typing, described concentration and probe concentration is 5-20 μ M.
Another technical scheme of the present invention is for providing a kind of method of HCV gene typing, and the method comprisesFollowing concrete steps:
A, design serotype specific primer and probe, described probe is as shown in claim 1 probe Y1-Y14, and described primer comprises contraryTranscribe primer RT:5 '-CGTCTAGCCATGGCGTTAGT-3 ';
Upstream primer F:5 '-GAAAGCGTCTAGCCATGGCGTTAGT-3 ';
Downstream primer R:5 '-CGCAAGCACCCTATCAGGCAGTA-3 ';
5 ' end of probe described in b, use active amino markers step a, and it is fixed on nylon membrane successively, detection madeFilm bar, carries out biotin labeling to the 5 ' end of described downstream primer R;
C, utilize primer described in step a to carry out HCVDNA amplification, by amplified production with detect the hybridization of film bar, with peroxideCompound enzyme and tetramethyl benzidine colour developing;
D, employing scanner, scanning hybridization signal, judges Genotyping result.
Preferably, the method for above-mentioned HCV gene typing, is also provided with colour developing and controls on described nylon membraneProbe CC, described colour developing control probe CC sequence is as follows: 5 '-GCGCAGGGCCACAATAATGG-3 ', described colour developing control5 ' the end of probe CC carries out amino labeled, and 3 ' end carries out biotin labeling.
Preferably, the method for above-mentioned HCV gene typing, the primer in described step a also comprises:
Internal reference primers F 1:5 '-TCATCGTCGCTGGAGCTGGTT-3 ';
Internal reference primer R1:5 '-CGGCGGTTTGTCAAGCTGAT-3 ';
Probe in described step a also comprises:
Internal reference probe PC:5 '-TGCCGATATAGGTCACAGCATGGGC-3 ';
5 ' end of described internal reference primers F 1 carries out biotin labeling.
The genetic chip of HCV gene typing of the present invention and kit and method have quick, sensitive, accurateReally, high-throughout feature, one time hybridization reaction can detect multiple target sequence, draws materials conveniently, without special installation, instrument drops intoLow, have fast and convenient, susceptibility is high and the feature of high specificity.
Brief description of the drawings
Fig. 1: the arrangement schematic diagram of HCV probe of the present invention on nylon membrane;
Fig. 2: 1 type HCV Virus Sample testing result scintigram;
Fig. 3: 2 type HCV Virus Sample testing result scintigrams;
Fig. 4: 3 type HCV Virus Sample testing result scintigrams;
Fig. 5: 6 type HCV Virus Sample testing result scintigrams.
Detailed description of the invention
By describing technology contents of the present invention, structural feature in detail, being realized object and effect, below in conjunction with embodimentAnd coordinate accompanying drawing to be explained in detail.
The object of the invention is to prepare a kind of HCV (HCV) gene typing DNA hybond membrane bar, a large amount of to meetBlood sample carries out the quick and precisely needs of somatotype of HCV.
For this reason, the present invention by the following technical solutions: adopt reversal point hybridization technique (ReverseDotBlot, RDB),With nylon membrane, as solid phase carrier, the specific oligonucleotide probe designing for HCV different genotype, by each HCV specificityProbe is fixed on film bar in the mode of round dot, is prepared into DNA hybond membrane bar, and with biotin labeling primer, sample to be checked increasesObject nucleic acid fragment, obtain with biotin labeled amplified production; Assorted with the film bar of fixing various oligonucleotide probes againHand over, by integrated enzyme reaction and colour developing, after scanning, with professional spot-analysis software, image is identified, removed background, carries outObjectively signal value analysis, thus judge in amplified production whether have the gene order for various oligonucleotide probes, at knotIn fruit judgement, reduce the subjective factors of artificial identification, be more suitable for Clinical detection application.
The present invention is directed to other gene order of HCV different shaped, design a set of specific oligonucleotide probe (as shown in table 1For sequence oligonucleotide probe and the type that detects), adopt automatic point sample instrument, probe is printed on to the spy of a nylon membraneDetermine region, judge the type of HCV according to the difference in colour developing site.
On the basis of above-mentioned DNA hybond membrane bar, be equipped with again other necessary component, as PCR primer (is as shown in table 2lyThe primer sequence that the present invention is used), form complete product. In the time that reality detects, get the HCV sample of nucleic acid solution of extraction,Adopt biotin labeling primer and asymmetric PCR method, amplify the HCV genome biotin labeling target sheet that may existSection. Get one of DNA hybond membrane bar, add PCR product 45 μ L to hybridize, hybridization temperature is set as 45 DEG C, 60 points of hybridization timeClock, through hybridization-washing-colour developing. Take out film bar and dry, put into scanner and scan, use analysis software to scan imageSignal carries out view data conversion process, and analyzes generation sample HCV type result.
According to another preferred embodiment of the present invention, introducing interior reference for the PCR system of sample amplificationThing, and internal reference template, and time prepared by film bar, introduced the probe that can hybridize with internal reference template, can be to PCR processCarry out effective mass control.
According to another preferred embodiment of the present invention, in the time preparing film bar, introduce colour developing and controlled probe (CC.),At one end of probe mark-NH2, with nylon membrane coupling, the other end is introduced biotin labeling, can directly develop the color. CCIntroducing can carry out effective mass control to process color.
Another preferred embodiment according to the present invention, the sheet base carrier of DNA hybond membrane bar can be slide, nylon membraneOr other can adhesion probe carrier.
Table 1
Table 2
Embodiment
1,5 ' UTR district design RT and PCR primer in HCV genome, adopts asymmetric RT-PCR system, amplification somatotype instituteThe target fragment needing; As shown in table 1, within the scope of target fragment, 3 of design 1 type probes, 24 of type probes, 3 type probes 3Bar, 1 of 6 three of type probes and general probe.
2, refer to Fig. 1 by nylon membrane by the format print grid designing, adopt automatically some film instrument, 14 somatotypes are visitedPin and 2 contrast probe points system, to the specific region of film bar, is made DNA hybond membrane bar.
Point sample probe solution: by probe dilution to 5 × SSC, 0.05%SDS solution, final concentration is 10 μ M;
Point sample matrix: by probe points on film bar, each probe point sample 0.5pM, every row 8 points, totally 2 row (referring to Fig. 1).
3, use product of the present invention to detect clinical sample
Get various other clinical sample 6 examples and positive and negative and contrast each portion, extract RNA, prepare RT-PCR according to table 3 anti-Answer system, each primer is as shown in table 3, carries out pcr amplification, obtains DNA hybridization template.
Table 3
Reagent1 person-portion (μ L)
Pure water21.5
10×PCR buffer5
25mM MgCl26
dNTP(10mM)1
10μM F2
10μM R1
10μM F12
10μM R11
Reverse transcriptase/Taq enzyme0.5
RNA template10
Total amount50
Pcr amplification program is as follows:
Adopt HCV Genotyping hybond membrane bar of the present invention, above sample is detected.
Get a hybond membrane bar, marker samples numbering, puts into hybrid pipe, get respectively the each 45 μ L of 8 pipe PCR product be added to rightIn the pipe that should number, set 45 DEG C of hybridization temperatures, hybridization time 60 minutes. After hybridization, wash, coupling, colour developing and air-dry.Concrete operations are as follows:
1) hybridization:
Get 15mL centrifuge tube, put into 1 of label film bar, add 5-8ml preheating A liquid (2*SSC, 0.5%SDS), corresponding40ulPCR product, covers tightly pipe lid, puts into vibration tank, 50 DEG C of jogs (100~150 revs/min), 40 minutes. Discard liquid.
2) coupling: (at every turn can simultaneously process 5 film bars)
Get 50mL centrifuge tube, preheating B liquid (0.5*SSC, 0.5%SDS) 20ml, C liquid (0.01%TMB) 1ml, mixes, and putsEnter hybond membrane bar, 50 DEG C of jogs (40~50 revs/min) 10 minutes, discard liquid;
Add preheating B liquid (0.5*SSC, 0.5%SDS) 40ml, 50 DEG C of jogs 3 minutes, discard liquid; Add D liquid (0.5M lemonAcid sodium, pH5.5) 40ml, 50 DEG C of jogs 3 minutes, discard liquid.
3) colour developing: (can process 5-10 at every turn simultaneously and open film bar)
Get 50mL centrifuge tube, add D liquid (0.5M natrium citricum, pH5.5) 20ml, E liquid 1ml (0.025%POD), F liquid(0.3H2O2) 1ml, mix and be nitrite ion, put into film bar and leave standstill 8 minutes in room temperature lucifuge, discard liquid;
Add D liquid (0.5M natrium citricum, pH5.5) 40ml, jog 3 minutes, discards liquid. Hybridization completes.
Adopt scanner, scanning hybridization signal, obtains results of hybridization scintigram (seeing Fig. 2-Fig. 5), and image is converted toData.
Adopt analysis software, above data analysis is converted into the gene type of each sample, meanwhile, by 8 partsSample DNA order-checking, contrasts as testing result. Result shows, 8 these testing results of increment conform to completely with sample sequencing result(in table 4).
Embodiment has illustrated the advantage of product of the present invention aspect detection flux, once can make the sample of arbitrary number; InspectionSurvey the reliability (testing result conforms to completely with sample sequencing result) of accuracy aspect.
Table 4
Sample numberSequencing resultThis result of the testWhether conform to
011 type1 typeBe
022 types2 typesBe
031 type1 typeBe
043 types3 typesBe
053 types3 typesBe
066 types6 typesBe
071 type1 typeBe
086 types6 typesBe
The foregoing is only embodiments of the invention, not thereby limit the scope of the claims of the present invention, everyly utilize thisThe equivalent structure that bright description and accompanying drawing content are done or the conversion of equivalent flow process, or be directly or indirectly used in other relevant skillsArt field, is all in like manner included in scope of patent protection of the present invention.

Claims (4)

CN201210229235.9A2012-07-042012-07-04The kit of HCV gene typing and methodActiveCN102766701B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201210229235.9ACN102766701B (en)2012-07-042012-07-04The kit of HCV gene typing and method

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201210229235.9ACN102766701B (en)2012-07-042012-07-04The kit of HCV gene typing and method

Publications (2)

Publication NumberPublication Date
CN102766701A CN102766701A (en)2012-11-07
CN102766701Btrue CN102766701B (en)2016-05-04

Family

ID=47094267

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201210229235.9AActiveCN102766701B (en)2012-07-042012-07-04The kit of HCV gene typing and method

Country Status (1)

CountryLink
CN (1)CN102766701B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN103710464B (en)*2013-12-302015-03-11湖南圣维尔医学检验所有限公司HCV (Hepatitis c virus) genotype detection kit
CN103966363B (en)*2014-05-162016-05-04福州泰普生物科学有限公司A kind of kit of HCV gene typing
CN104131087B (en)*2014-07-112016-01-27武汉千麦医学检验所有限公司A kind of test kit carrying out gene type for folic acid metabolism gene
CN104152570B (en)*2014-08-252016-09-14武汉千麦医学检验所有限公司A kind of basal cell cancer susceptibility gene SNP polymorphic detection test kit
CN104357584A (en)*2014-11-042015-02-18中国人民解放军军事医学科学院放射与辐射医学研究所Preparation and application of guiding gene chip for HCV infection individual treatment
CN109593887B (en)*2018-12-292022-10-11广州达安基因股份有限公司Kit for quantitative detection of hepatitis C virus nucleic acid
CN115261518B (en)*2022-08-262023-06-06北京爱普益生物科技有限公司Primer combination, kit and application of hepatitis C virus genotyping

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP1076092A3 (en)*1994-10-212001-03-28Innogenetics N.V.Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents
CN1167812C (en)*2000-07-232004-09-22浙江江南生物科技有限公司Biochip for typing non-coding region gene of hepatitis C virus HCV5'
US7179600B2 (en)*2001-04-122007-02-20Biocore Co., Ltd.Oligonucleotide chip composition and a method for analyzing a hepatitis C virus genotype using the composition
US8067208B2 (en)*2005-06-302011-11-29Roche Molecular Systems, Inc.Probes and methods for hepatitis C virus typing using multidimensional probe analysis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GenBank: HQ113670.1;Li,H. et al.;《Genbank》;20110717;1-2*

Also Published As

Publication numberPublication date
CN102766701A (en)2012-11-07

Similar Documents

PublicationPublication DateTitle
CN102766701B (en)The kit of HCV gene typing and method
Cai et al.Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay
WO2021174674A1 (en)Composition, kit and method for detecting and typing coronaviruses
CN113215313A (en)Detection kit for coronavirus SARS-CoV-2 and mutant strain thereof and application thereof
CN106119413A (en)A kind of HIV (human immunodeficiency virus) multiple fluorescence PCR detection reagent box and detection method
IL189281A (en)In vitro diagnostic method and kit for identification of human papillomavirus in clinical samples
CN101392302A (en) Influenza/human avian influenza virus detection gene chip and its production method and application
CN106755535A (en)Primer, probe, kit and method for detecting mankind's CYP2C19 gene pleiomorphisms
CN105296673A (en)Influenza A virus molecular detection kit and preparation method thereof
CN105133040B (en)A kind of genetic chip for detecting Sea central platform and preparation method thereof and detection method
CN102586473A (en)Hepatitis B virus genotyping PCR (polymerase chain reaction) test kit
CN103966363B (en)A kind of kit of HCV gene typing
CN102251061A (en)Nucleic acid dual fluorescence PCR (Polymerase Chain Reaction) detection kit for influenza A/B virus
CN105112558B (en)The triple real time fluorescent quantitative RT PCR detection kits of the type of foot and mouth disease virus O, A and Asia I
CN105063760A (en)Gene chip for identification of seven swine disease pathogens and detection method thereof
CN101323882B (en)Primer set for detecting pig influenza virus and blood serum subtype and reagent box thereof
CN102286639A (en)Type A H1N1/influenza A virus nucleic acid dual fluorescent polymerase chain reaction (PCR) detection kit
CN102363818A (en)Treble real-time fluorescence quantitative polymerase chain reaction (PCR) method for simultaneously detecting epstein-barr virus (EBV), polyma virus (BKV) and cytomegalovirus (CMV) of people and kit
CN107523649A (en)H7N9 subtype influenza virus genome sequencing methods
CN101660002A (en)HCV genotyping DNA microarray chip
CN104357584A (en)Preparation and application of guiding gene chip for HCV infection individual treatment
CN105296675A (en)Nucleic acid detecting kit for influenza B viruses and preparation method of nucleic acid detecting kit
CN103225000B (en)Bird flu H7N9 virus detection reagents and detection kit
CN104293976A (en)Gene chip and kit for detecting pig epidemic type B encephalitis virus and/or pig porcine reproductive and respiratory syndrome virus
CN101586170A (en)Method and kits for detecting genotype of hepatitis B virus

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
C14Grant of patent or utility model
GR01Patent grant
PP01Preservation of patent right
PP01Preservation of patent right

Effective date of registration:20220411

Granted publication date:20160504

PD01Discharge of preservation of patent
PD01Discharge of preservation of patent

Date of cancellation:20240123

Granted publication date:20160504


[8]ページ先頭

©2009-2025 Movatter.jp